Abstract PS15-09: Imlunestrant Monotherapy and in Combination with Abemaciclib, with or Without an Aromatase Inhibitor, in Estrogen Receptor-Positive (ER+), HER2-negative (HER2-) Advanced Breast Cancer (abc): Updated Results from the EMBER Study